分子时代骨髓活检的定量解读在骨髓增殖性肿瘤中的意义
本综述聚焦骨髓组织图像分析与人工智能的最新进展,指出骨髓增殖性肿瘤(MPN)诊断需整合临床、形态学、遗传与免疫表型,而显微镜判读仍主观定性;图像分析有望细化反应性样本与MPN亚型的边界、捕捉高危疾病的形态学关联,并改进疗效评估。
要点
- MPN诊断需整合临床、形态学、遗传和免疫表型资料。
- 骨髓活检显微镜判读仍主观且定性,图像分析与人工智能有望改变血液病理学。
- 骨髓图像分析可细化反应性与MPN亚型边界,并捕捉高危疾病的形态学关联。
核心结论
- 图像分析/人工智能有望补充和指导未来MPN临床与研究,提供客观定量的疾病修饰指标。
研究设计与样本
- 综述,聚焦骨髓组织图像分析与人工智能的最新进展,重点讨论其在MPN未来临床研究中的潜在价值。
主要发现
- 骨髓图像分析的开创性研究有望细化反应性样本与MPN亚型之间的边界,并更好地捕捉高危疾病的形态学关联。
- 这些研究还显示,有潜力改进对MPN及其他血液肿瘤当前和新型治疗的评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The diagnosis of myeloproliferative neoplasms (MPN) requires the integration of clinical, morphological, genetic and immunophenotypic findings. Recently, there has been a transformation in our understanding of the cellular and molecular mechanisms underlying disease initiation and progression in MPN. This has been accompanied by the widespread application of high-resolution quantitative molecular techniques. By contrast, microscopic interpretation of bone marrow biopsies by haematologists/haematopathologists remains subjective and qualitative. However, advances in tissue image analysis and artificial intelligence (AI) promise to transform haematopathology. Pioneering studies in bone marrow image analysis offer to refine our understanding of the boundaries between reactive samples and MPN subtypes and better capture the morphological correlates of high-risk disease. They also demonstrate potential to improve the evaluation of current and novel therapeutics for MPN and other blood cancers. With increased therapeutic targeting of diverse molecular, cellular and extra-cellular components of the marrow, these approaches can address the unmet need for improved objective and quantitative measures of disease modification in the context of clinical trials. This review focuses on the state-of-the-art in image analysis/AI of bone marrow tissue, with an emphasis on its potential to complement and inform future clinical studies and research in MPN.
引用
- Ryou H, Lomas O, Theissen H, et al. Quantitative interpretation of bone marrow biopsies in MPN-What's the point in a molecular age? Br J Haematol. 2023. PMID: 37858962. doi:10.1111/bjh.19154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。